{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:32:19Z","timestamp":1780471939105,"version":"3.54.1"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2020.585275","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T17:22:56Z","timestamp":1605201776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Vasculitis in Cystic Fibrosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Francesca","family":"Sposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"B1","unstructured":"Cystic Fibrosis. Genetics Home Reference2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12016-007-8039-9","article-title":"Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling","volume":"34","author":"Nichols","year":"2008","journal-title":"Clinic Rev Allerg Immunol."},{"key":"B3","unstructured":"Cystic Fibrosis Mutation Database"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1002\/ppul.23242","article-title":"Inflammation and its genesis in cystic fibrosis: inflammation in cystic fibrosis","volume":"50","author":"Nichols","year":"2015","journal-title":"Pediatr Pulmonol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1385\/CRIAI:23:1:005","article-title":"The role of inflammation in the pathophysiology of CF lung disease","volume":"23","author":"Chmiel","year":"2002","journal-title":"CRIAI."},{"key":"B6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"MBoC."},{"key":"B7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"key":"B8","first-page":"609","article-title":"Vasulitis complicating cystic fibrosis","volume":"72","author":"Finnegan","year":"1989","journal-title":"Int J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1000104","DOI":"10.35248\/2684-1436.16.1.104","article-title":"Cutaneous vasculitis associated to cystic fibrosis","volume":"1","author":"Ruiz Beguerie","year":"2016","journal-title":"J Dermatitis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1186\/ar2193","article-title":"Vasculitis: mechanisms involved and clinical manifestations","volume":"9","author":"Guillevin","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1525-1470.1987.tb00763.x","article-title":"Recurrent cutaneous vascuiitis in cystic fibrosis","volume":"4","author":"Fradin","year":"1987","journal-title":"Pediatr Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"bcr0320102834","DOI":"10.1136\/bcr.03.2010.2834","article-title":"Recurrent vasculitis in cystic fibrosis","volume":"2010","author":"Wujanto","year":"2010","journal-title":"Case Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/jaut.1997.0186","article-title":"Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis","volume":"11","author":"\u0160ediv\u00e1","year":"1998","journal-title":"J Autoimmun."},{"key":"B14","first-page":"529","article-title":"Immune complexes in human diseases","volume":"100","author":"Theofilopoulos","year":"1980","journal-title":"Am J Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fped.2018.00421","article-title":"Childhood vasculitis","volume":"6","author":"Schnabel","year":"2019","journal-title":"Front Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3389\/fimmu.2018.00558","article-title":"Inhibition of immune complex complement activation and neutrophil extracellular trap formation by peptide inhibitor of complement C1","volume":"9","author":"Hair","year":"2018","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2015.01.022","article-title":"Immune complexes: not just an innocent bystander in chronic viral infection","volume":"42","author":"Wang","year":"2015","journal-title":"Immunity."},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.mi.40.100186.000333","article-title":"The role of immune complexes in the pathogenesis of bacterial infections","volume":"40","author":"Hoiby","year":"1986","journal-title":"Annu Rev Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1159\/000096960","article-title":"Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?","volume":"105","author":"van Paassen","year":"2007","journal-title":"Nephron Exp Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000463084","article-title":"Drug-induced immune-complex disease","volume":"6","author":"Sim","year":"1989","journal-title":"Complement Inflamm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/pharmacy7030122","article-title":"Antibiotic hypersensitivity mechanisms","volume":"7","author":"Maker","year":"2019","journal-title":"Pharmacy."},{"key":"B22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0732-8893(00)00238-8","article-title":"Cutaneous leucocytoclastic vasculitis associated with oxacillin","volume":"39","author":"Koutkia","year":"2001","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ccr3.992","article-title":"Cefazolin as a cause of leukocytoclastic vasculitis","volume":"5","author":"Ali","year":"2017","journal-title":"Clin Case Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.autrev.2016.07.016","article-title":"The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"15","author":"Weiner","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1681\/ASN.2014090903","article-title":"Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"JASN."},{"key":"B26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2249.1995.tb03471.x","article-title":"Bactericidal\/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis","volume":"99","author":"Zhao","year":"2008","journal-title":"Clin Exp Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2169\/internalmedicine.52.9477","article-title":"Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal\/permeability increasing protein","volume":"52","author":"Fukuhara","year":"2013","journal-title":"Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1183\/09031936.00006009","article-title":"Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis","volume":"34","author":"Lachenal","year":"2009","journal-title":"Eur Respir J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jcf.2019.06.006","article-title":"Dissociation of systemic and mucosal autoimmunity in cystic fibrosis","volume":"19","author":"Theprungsirikul","year":"2019","journal-title":"J Cystic Fibrosis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1755-7682-1-24","article-title":"Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers","volume":"1","author":"Coutinho","year":"2008","journal-title":"Int Arch Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fcimb.2017.00104","article-title":"Understanding the entanglement: neutrophil extracellular traps (NETs) in cystic fibrosis","volume":"7","author":"Mart\u00ednez-Alem\u00e1n","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jcf.2018.12.010","article-title":"Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis","volume":"18","author":"Yadav","year":"2019","journal-title":"J Cystic Fibrosis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1056\/NEJMe1303487","article-title":"Identifying the origins of cystic fibrosis lung disease","volume":"368","author":"Davis","year":"2013","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jcf.2010.08.017","article-title":"Treatment of cystic fibrosis associated cutaneous vasculitis with chloroquine","volume":"9","author":"Molyneux","year":"2010","journal-title":"J Cystic Fibrosis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Saint-Criq","year":"2017","journal-title":"Cell Mol Life Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2S4","DOI":"10.1002\/ppul.23247","article-title":"CFTR, bicarbonate, and the pathophysiology of cystic fibrosis: CFTR, bicarbonate, and the pathophysiology of CF","volume":"50","author":"Borowitz","year":"2015","journal-title":"Pediatr Pulmonol."},{"key":"B38","first-page":"p. 3799","article-title":"Cystic fibrosis","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Welsh","year":"1995"},{"key":"B39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcf.2006.10.005","article-title":"Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis","volume":"6","author":"Carlsson","year":"2007","journal-title":"J Cystic Fibrosis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-3083.2012.02775.x","article-title":"Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis","volume":"76","author":"Aanaes","year":"2012","journal-title":"Scand J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3389\/fimmu.2019.01334","article-title":"The pathogenicity of BPI-ANCA in a patient with systemic vasculitis","volume":"10","author":"Takeda","year":"2019","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jbspin.2016.05.013","article-title":"NETosis: at the crossroads of rheumatoid arthritis, lupus, and vasculitis","volume":"84","author":"Berthelot","year":"2017","journal-title":"Joint Bone Spine."},{"key":"B43","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","article-title":"A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis","volume":"8","author":"Metzler","year":"2014","journal-title":"Cell Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13330","DOI":"10.1073\/pnas.96.23.13330","article-title":"Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation","volume":"96","author":"Dibbert","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000295791","article-title":"In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance","volume":"2","author":"Moriceau","year":"2010","journal-title":"J Innate Immun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"10260","DOI":"10.1021\/bi060490t","article-title":"CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis\u2020","volume":"45","author":"Painter","year":"2006","journal-title":"Biochemistry."},{"key":"B48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/thoraxjnl-2017-210134","article-title":"Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis","volume":"73","author":"Gray","year":"2018","journal-title":"Thorax."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/art.23596","article-title":"Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e98794","DOI":"10.1371\/journal.pone.0098794","article-title":"Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease","volume":"9","author":"Giles","year":"2014","journal-title":"PLoS ONE."},{"key":"B51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/OARRR.S166070","article-title":"Current perspectives on emerging biomarkers for rheumatoid arthritis-associated interstitial lung disease","volume":"11","author":"Amigues","year":"2019","journal-title":"OARRR."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1159\/000453162","article-title":"CFTR controls the activity of NF-kB by enhancing the degradation of TRADD","volume":"40","author":"Wang","year":"2016","journal-title":"Cell Physiol Biochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.18388\/abp.2015_1055","article-title":"Selected mucolytic, anti-inflammatory and cardiovascular drugs change the ability of neutrophils to form extracellular traps (NETs)","volume":"62","author":"Zawrotniak","year":"2015","journal-title":"Acta Biochim Pol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e23637","DOI":"10.1371\/journal.pone.0023637","article-title":"Neutrophil extracellular trap (NET)-mediated killing of pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR","volume":"6","author":"Young","year":"2011","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/1753425918785008","article-title":"Lipoxin A 4 attenuates LPS-induced acute lung injury via activation of the ACE2-Ang-(1-7)-Mas axis","volume":"24","author":"Chen","year":"2018","journal-title":"Innate Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.thromres.2017.12.012","article-title":"Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status","volume":"162","author":"Lindberg","year":"2018","journal-title":"Thromb Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41385-018-0013-8","article-title":"Increased intracellular Cl\u2013 concentration promotes ongoing inflammation in airway epithelium","volume":"11","author":"Zhang","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3389\/fimmu.2019.01789","article-title":"Metabolic reprograming of cystic fibrosis macrophages via the IRE1\u03b1 arm of the unfolded protein response results in exacerbated inflammation","volume":"10","author":"Lara-Reyna","year":"2019","journal-title":"Front Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3410\/f.1008963.128907","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell."},{"key":"B61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e13079","DOI":"10.1111\/cmi.13079","article-title":"Canonical and noncanonical inflammasomes in intestinal epithelial cells","volume":"21","author":"Winsor","year":"2019","journal-title":"Cell Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1161\/CIRCRESAHA.116.308501","article-title":"Caspase-1 inflammasome activation mediates homocysteine-induced pyrop-apoptosis in endothelial cells","volume":"118","author":"Xi","year":"2016","journal-title":"Circ Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00393-016-0077-3","article-title":"Caspase-1 regulates autoinflammation in rheumatic diseases","volume":"75","author":"Winkler","year":"2016","journal-title":"Zeitschr Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e49248","DOI":"10.7554\/eLife.49248","article-title":"ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis","volume":"8","author":"Scambler","year":"2019","journal-title":"Elife."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e54556","DOI":"10.7554\/eLife.54556","article-title":"Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis","volume":"9","author":"Jarosz-Griffiths","year":"2020","journal-title":"Elife."},{"key":"B67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2016.03.002","article-title":"Shaping the spectrum \u2014 from autoinflammation to autoimmunity","volume":"165","author":"Hedrich","year":"2016","journal-title":"Clin Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vph.2018.04.006","article-title":"Innate and adaptive immunity in atherosclerosis","volume":"107","author":"Miteva","year":"2018","journal-title":"Vasc Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jcf.2019.07.005","article-title":"The role of endothelial cells in cystic fibrosis","volume":"18","author":"Declercq","year":"2019","journal-title":"J Cystic Fibrosis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"C1555","DOI":"10.1152\/ajpcell.1998.275.6.C1555","article-title":"Characterization of CFTR expression and chloride channel activity in human endothelia","volume":"275","author":"Tousson","year":"1998","journal-title":"Am J Physiol Cell Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.bbadis.2017.08.011","article-title":"Mechanisms of endothelial cell dysfunction in cystic fibrosis","volume":"1863","author":"Totani","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0006-291X(05)80095-6","article-title":"Human neutrophils exhibit disparate chemotactic factor gene expression","volume":"173","author":"Strieter","year":"1990","journal-title":"Biochem Biophys Res Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0022-3476(79)80650-2","article-title":"Cutaneous necrotizing venulitis in patients with cystic fibrosis","volume":"95","author":"Soter","year":"1979","journal-title":"J Pediatr"},{"key":"B74","doi-asserted-by":"publisher","first-page":"205427041769273","DOI":"10.1177\/2054270417692732","article-title":"Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series","volume":"8","author":"Kayria","year":"2017","journal-title":"JRSM Open."},{"key":"B75","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2014.10.020","article-title":"Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms","volume":"14","author":"Konstantinov","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"286783","DOI":"10.1155\/2015\/286783","article-title":"Pathophysiological relationship between infections and systemic vasculitis","volume":"2015","author":"Mu\u00f1oz-Grajales","year":"2015","journal-title":"Autoimmune Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"B79","doi-asserted-by":"publisher","first-page":"10791","DOI":"10.1038\/ncomms10791","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis","volume":"7","author":"Iannitti","year":"2016","journal-title":"Nat Commun."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s40265-019-01233-7","article-title":"Elexacaftor\/ivacaftor\/tezacaftor: first approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.585275\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T17:23:15Z","timestamp":1605201795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.585275\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":81,"alternative-id":["10.3389\/fped.2020.585275"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.585275","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"article-number":"585275"}}